Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a4528f1f3998eefa

Jump to content

Uterine hyperstimulation

From Wikipedia, the free encyclopedia

Uterine hyperstimulation or hypertonic uterine dysfunction is a potential complication of labor induction. This is displayed as Uterine tachysystole- the contraction frequency numbering more than five in a 10-minute time frame or as contractions exceeding more than two minutes in duration.[1] Uterine hyperstimulation may result in fetal heart rate abnormalities, uterine rupture, or placental abruption. It is usually treated by administering terbutaline.[2]

Causes

[edit]
  • Mistoprostol is a drug treatment for peptic ulcers that can also cause abortion or induce labor. The use of this drug (inserted vaginally) to induce labor can cause uterine hyperstimulation.

Treatment

[edit]

Treatments of uterine hyperstimulation are primarily experimental. Those that have shown to alleviate the conditions are:

  • Prostoglandin E2 is administered before labor to minimize risk of uterine hyperstimulation and to minimize the effects on Fetal Heart Rate.
  • Administration of tocolytic treatment with β2-adrenergic drugs has shown to stabilize uterine contractions while also effectively lowering Fetal Heart Rate.
  • The usage of a balloon catheter to induce labor rather than Prostoglandin E2 lowers the risk of uterine hyperstimulation and its effect on fetal heart rate.

References

[edit]
  1. ↑ Briggs GG, Wan SR (June 2006). "Drug therapy during labor and delivery, part 2". Am J Health Syst Pharm. 63 (12): 1131–9. doi:10.2146/ajhp050265.p2. PMID 16754739. Retrieved 2009-08-03., which cites:
    American College of Obstetricians and Gynecologists (December 1999). "Induction of labor". ACOG Practice Bulletin. 10. Washington, DC.
  2. ↑ Briggs GG, Wan SR (June 2006). "Drug therapy during labor and delivery, part 2". Am J Health Syst Pharm. 63 (12): 1131–9. doi:10.2146/ajhp050265.p2. PMID 16754739. Retrieved 2009-08-03.